<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>1 </plain></SENT>
<SENT sid="1" pm="."><plain>The polymorphonuclear neutrophils (PMN) activation and mobilization observed in <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> contribute to the brain tissue damage, but PMN could also be involved in postischemic functional injury of ischemied blood vessel </plain></SENT>
<SENT sid="2" pm="."><plain>2 </plain></SENT>
<SENT sid="3" pm="."><plain>This study was undertaken to investigate whether pharmacological <z:hpo ids='HP_0001875'>neutropenia</z:hpo> could modify the postischemic <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> in comparison to smooth muscle whose impairment is likely more related to reperfusion and <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>3 </plain></SENT>
<SENT sid="5" pm="."><plain>A <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>-reperfusion by endoluminal occlusion of right middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>) was performed 4 days after intravenous administration of vinblastine or 12 h after RP-3 anti-rat neutrophils monoclonal antibody (mAb RP-3) injection into the peritoneal cavity, on male Wistar rats with 1-h <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> then followed by 24-h reperfusion period </plain></SENT>
<SENT sid="6" pm="."><plain>Brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volume was measured by histomorphometric analysis and vascular endothelial and smooth muscle reactivity of <z:chebi fb="70" ids="34342">MCA</z:chebi> was analysed using Halpern myograph </plain></SENT>
<SENT sid="7" pm="."><plain>4 </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0001875'>Neutropenia</z:hpo> induced a neuroprotective effect as demonstrated by a significant decrease of brain <z:mpath ids='MPATH_124'>infarct</z:mpath> size </plain></SENT>
<SENT sid="9" pm="."><plain>In parallel to neuroprotection, <z:hpo ids='HP_0001875'>neutropenia</z:hpo> prevented postischemic impairment of endothelium-dependent relaxing response to <z:chebi fb="9" ids="15355">acetylcholine</z:chebi> </plain></SENT>
<SENT sid="10" pm="."><plain>In contrast, smooth muscle functional alterations were not prevented by <z:hpo ids='HP_0001875'>neutropenia</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain><z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">Ischemia</z:e>-reperfusion-induced myogenic tone impairment remained unchanged in vinblastine and mAb RP-3-treated rats </plain></SENT>
<SENT sid="12" pm="."><plain>Postischemic Kir2.x-dependent relaxation impairment was not prevented in neutropenic conditions </plain></SENT>
<SENT sid="13" pm="."><plain>The fully relaxation of smooth muscle response to <z:chebi fb="0" ids="29321">sodium nitroprusside</z:chebi> was similar in <z:hpo ids='HP_0000001'>all</z:hpo> groups </plain></SENT>
<SENT sid="14" pm="."><plain>5 </plain></SENT>
<SENT sid="15" pm="."><plain>Our results evidenced the dissociate prevention of pharmacologically induced <z:hpo ids='HP_0001875'>neutropenia</z:hpo> on postischemic vascular endothelial and smooth muscle impairment </plain></SENT>
<SENT sid="16" pm="."><plain>The selective endothelial protection by <z:hpo ids='HP_0001875'>neutropenia</z:hpo> is parallel to a neuroprotective effect suggesting a possible relationship between the two phenomena </plain></SENT>
</text></document>